KNOXVILLE, Tenn., July 28, 2016 -- Officials with The University of Tennessee Medical Center (UTMC) have announced evidence that the sharing of snorting utensils, such as straws, when abusing illicit drugs can transmit Hepatitis C (HCV) and other blood-borne viruses like HIV from person to person.
|
|||||
The results of this research have been officially published in Obstetrics & Gynecology (a.k.a. The Green Journal), the official publication of the American College of Obstetricians & Gynecologists and may be accessed by clicking here.
"This is a worldwide issue that needs to be addressed," said Dr. Craig Towers, maternal-fetal medicine specialist with High Risk Obstetrical Consultants, the division of Maternal-Fetal Medicine at UTMC, and lead physician on the study.
"The idea that 'if you snort, don't share straws' needs to be communicated around the globe as the use of snorting straws for drug-use is a common practice, especially for those that prefer that method over intravenous drug use," said Towers.
According to Towers, the national impact of the study is of particular interest as the most common chronic blood-borne infection in the United States is HCV. Since Towers' study was conducted on women living in the greater Eastern Tennessee region, the study supports previous stats proving the overwhelming existence of an "opioid epidemic," especially in Appalachia.
"Previous reports have shown a 364% increase in HCV infections from 2006 to 2012 in the central Appalachian region," said Towers. "The main concern is the transmission of any blood-borne virus, but a huge potential impact of the sharing of snorting utensils is the threat of transmitting HIV, which is more serious than HCV. If HIV were to enter the blood pool of this population, an increase in this serious infection might also develop."
In the 16-month study (March of 2014 through June of 2015), Towers' goal was to evaluate possible modes of HCV acquisition in HCV-infected pregnant patients in Eastern Tennessee through known common routes such as intravenous drug usage, blood transfusion, organ transplant, sexual contact, and tattoos, as well as possible straw transmission. Therefore, an anonymous survey was distributed to 189 women who had tested positive for HCV post-routine blood testing at Towers' obstetrics clinic at UTMC.
"Because of the high rates of HCV-infections we've seen, HCV testing has become part of the routine prenatal screening at High Risk Obstetrical Consultants," said Towers.
Towers explains this group of pregnant women was specifically chosen for the study because pregnancy provides a population that is often more motivated for healthcare intervention due to the potential effects on the unborn child.
According to Towers, of the study's 189 participants, 133 participants (70%) did not have any idea when they had become infected with HCV and 127 (67%) were first told they had HCV following the prenatal lab work that was obtained during routine prenatal care. Additionally, of the women surveyed, 164 (92%) reported sharing snorting straws.
"Nearly all participants reported that opiates were the primary drug that was snorted," said Towers. "In addition, the opiates used intravenously and snorted in the Appalachian region are crushed prescription drugs, which is evidence of the neonatal abstinence syndrome (NAS) epidemic that also exists in our region and has been the basis of some of my previous research studies."
Towers concludes that the sharing of snorting straws in the process of snorting opiates or any other drugs may be an additional risk factor for becoming infected with HCV and other blood-borne infections.
"This risk needs to be communicated to the public and the healthcare community," said Towers.
Towers says the next phase of his research will study the risk of HCV being transmitted to babies during birth.
About UT Medical Center
The mission of The University of Tennessee Medical Center, the region's only hospital to achieve status as a Magnet® recognized organization, is to serve through healing, education and discovery. UT Medical Center, a 609-bed, not-for-profit academic medical center, serves as a referral center for Eastern Tennessee, Southeast Kentucky and Western North Carolina. The medical center, the region's Level I Trauma Center, is one of the largest employers in Knoxville. For more information about The University of Tennessee Medical Center, visit online at www.utmedicalcenter.org.
# # #
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=40942
CONTACT: Jim Ragonese
[email protected]
(865) 305-6845


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



